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Abstract (240 words) 
Background and Purpose 
The ABC/2 method for calculating ICH volume has been well validated. However the 
formula, derived from the volume of an ellipse, assumes the shape of ICH is elliptical. 
We sought to compare the agreement of the ABC/2 formula to other methods through 
retrospective analysis of a selection of the STICH II cohort. 
Methods 
739 scans from 390 patients were selected from the STICH II image archive based on 
the availability of a CT scan compatible with OsiriX DICOM viewer. ICH volumes 
were calculated by the reference standard semi-automatic segmentation in OsiriX 
software and compared to calculated arithmetic methods (ABC/2, ABC/2.4, ABC/3, 
2/3SC) volumes. Volumes were compared by difference plots for specific groups: 
randomisation ICH (n=374), 3-7 day post surgical ICH (n=206), antithrombotic 
associated ICH (n=79), irregular shape ICH (n=703) and irregular density ICH 
(n=650). Density and shape were measured by the Barras ordinal shape and density 
groups (1-5).  
Results 
The ABC/2.4 method had the closest agreement to the semi automatic segmentation 
volume in all groups; except for the 3-7 day post surgical ICH group where the 
ABC/3 method was superior. 
Conclusions 
Whilst the ABC/2 formula for calculating elliptical ICH is well validated, it must be 
employed with caution in ICH scans where the elliptical shape of ICH is a false 
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assumption. We validated the adjustment of the ABC/2.4 method in randomisation, 
antithrombotic associated, heterogeneous density and irregular shape ICH.  
Clinical Trial Registration: ISRCTN22153967. 
http://www.isrctn.com/ISRCTN22153967 
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Introduction  
Spontaneous intracerebral haemorrhage (ICH) has a >40% mortality at 30 days1 and 
most survivors are left disabled2. Initial haemorrhage volume has been well 
documented as one of the variables for predicting patient outcome3 and included in 
the ICH score4 for predicting patient mortality. Moreover, ICH volume at ictus is an 
outcome measure and safety criterion for current clinical trials that are hoped to 
improve patient outcomes in future (MISTIE III, NCT01827046) .5, 6 Paramount to 
this work is having an accurate and expedient method for quantifying ICH volume 
from patient’s neuroimaging. Multiple methods exist currently to perform this task, 
with the ABC/2 method being the most validated.3 The ABC/2 method approximates 
ICH volume to the volume of an ellipsoid (4/3πr3).3 In the formula, A = the longest 
diameter of haemorrhage on the largest slice of haematoma, B = the longest 
perpendicular diameter to A, C = the depth of haematoma (calculated as the number 
of slices with haemorrhage multiplied by slice thickness).3 Whilst the ABC/2 formula 
has been validated for small to moderately sized elliptical haemorrhages7,8, there is 
still debate about the validity of the ABC/2 method in quantifying ICH in the 
following groups  9-18:  
1. ICH at randomisation in the STICH II trial  
2. Day 3-7 post surgical ICH 
3. Antithrombotic associated ICH  
4. Irregularly sized ICH 
5. Heterogeneous density ICH 
Studies have validated the following adjustments: ABC/2.4 16, ABC/3 17 and 2/3SC 
(where S= the area of largest haemorrhage on axial slice methods) 9-11, 18 . We 
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therefore set out to describe the agreement of the methods available to quantify ICH 
volume, in comparison to a reference standard semiautomatic method (which makes 
no assumptions about the shape of the haematoma) for calculating ICH volume in 
these groups from the STICH II19 cohort.  
Methods 
Clinical protocol 
Participants came from STICH II, an international prospective multi-centre 
randomised trial of early surgery versus initial conservative therapy for lobar ICH at 
78 sites across 27 countries.19 Full details of original trials ethics and regulatory 
approval, alongside full inclusion criteria are accessible: 
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)60986-1/fulltext . 
Patients in this trial were randomised to early surgery (within 48 hours) or initial 
conservative therapy. Patients had two scans in this trial, one as part of routine clinical 
care (diagnostic) pre randomisation and another at between 3 to 7 days later. This 
study assesses only those patients with open source DICOM viewer (OsiriX Lite v.6.5 
32-bit, PIXMEO, Geneva; Switzerland) compatible CT scans, with or without 
contrast. For each patient, images were received with the thinnest slices provided by 
CT scan machines using standardised protocols in the recruiting centres. Newcastle 
University Ethics Committee exempted ethical approval for this study, which was 
conducted in accordance with the Declaration of Helsinki.  
CT Analysis 
601 patients were recruited in the STICH II indicating a potential 1202 scans. Patients 
scans were selected as described in Supplementary Figure I. Approximately 34% (411 
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scans) were not compatible with the semi automatic segmentation software, using an 
open source DICOM viewer (OsiriX Lite v.6.5 32-bit, PIXMEO, Geneva; 
Switzerland) for Mac OS. The final 739 scans were read by one reader (MH) in 
normally light office conditions using a 13 inch MacBook Pro connected to a 19 inch 
visual display (DELL P190S) with a Bluetooth connected mouse (MICROSOFT, 
Notebook mouse 5000). Scans were read randomly, in an order chosen by the 
computer and paired scans were read blind to each other. All scans were read with 
window levels set to “CT – Brain” view (window length 50 Hounsfield units (HU), 
window width 100 HU). The area of ICH on each slice was semi-automatically 
delineated using the OsiriX “grow region” and “repulsor” tools. Boundaries of 40-80 
HU were applied to define blood on CT. Particular attention was paid to avoid the 
inclusion of the cranium and areas of calcification in volume calculations. After 
accurately defining the haemorrhage, volumes were calculated by the OsiriX software 
and the result recorded in cubic centimetres (cm3). These are defined as region of 
interest (ROI) volumes.       
 Four arithmetic methods were tested against ROI for this study (ABC/2, 
ABC/2.4, ABC/3 and 2/3SC).  For each, the largest slice area of haematoma (S) was 
identified automatically by voxel counts for each slice. Maximum diameter on this 
slice was measured in centimetres (cm) and recorded as the ‘A’ measurement. 
Maximum diameter 90° to ‘A’ was measured in cm and recorded as ‘B’. On regular 
slice thickness scans ‘C’ was calculated, in cm, as a product of the number of slices 
with ICH and the regular slice thickness in cm. Slice thickness ranged from 0.1-1cm 
in this study. Modified ABC/2 approaches that weight the contribution of slices to the 
C axis based on the proportion of blood relative to the largest slice, do not respect the 
3 Cartesian axes fundamental to the ABC/2 method and are not recommended.7 
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Arithmetic (e.g. ABC/2) volumes were not simultaneously calculated to limit bias. 
Shape and density measures from each haematoma were measured by one reader 
(MH) as ordinal variables using the Barras et al.20 method on the largest slice of 
haemorrhage, where each point adds an additional shape irregularity or density 
heterogeneity. Categories 1 and 2 were combined and defined as regular shape or 
homogenous density and 3 to 5 were combined and defined as irregular or 
heterogeneous. The antithrombotic associated ICH group was based on the original 
study data, with 79 patients on one or more of anticoagulants, antiplatelets or 
thrombolytics premorbidly. Postoperative ICH was defined as any ICH remaining 
radiologically after a surgical procedure (decompression and/or complete evacuation). 
Particular attention was paid in these studies not to include any areas of the cranial 
bone or blood present within the intraventricular, subarachnoid, subdural, extra dural 
or extra cranial spaces. In the postoperative CT scan, all intracerebral haematoma was 
included. Scans were examined and measured at random from the image archive. 
Randomisation scans and 3-7 day scans were analysed separately as they presented 
different issues. In particular a large number of 3-7-day scans were post procedure 
and if there was no ICH remaining (volume equal to zero) they were excluded.  
Statistical Analysis 
Differences in patient and scan characteristics between STICH II and the selected 
groups were assessed (Table I and II). Difference plots for ICH volume (Figures 1-4 
and Supplementary Figure III) show arithmetic method minus semi-automated 
method, versus arithmetic mean volume. Using the approach of Bland and Altman, 
linear regression of residuals against mean volume was employed to account for the 
variations in volume difference with volume magnitude.21 95% regression based 
limits of agreement are demonstrated. The fisher’s exact test was used to compare 
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proportions of scans within specified categories. All measures were rounded to 2 
decimal places. The Authors declare that all supporting summary data is available 
within the article. The manuscript complies with the American Heart Association 
Journals’ Transparency and Openness (TOP) guidelines.  
Results 
Summary characteristics 
Patients at baseline were well matched with the exception of the antithrombotic 
associated ICH group (Table 1). This group had a tendency to be older and have more 
comorbidities. Scans characteristics (Table 2) showed an interesting propensity for 
right sided and deep haemorrhages in the antithrombotic associated group. Moreover 
there were a greater number of frontal and occipital haemorrhages in this group, with 
proportionately less temporal and parietal haematomas. ROI volumes in this group 
were large, perhaps unsurprising due to premorbid antithrombotic use. 
Intraventricular haemorrhage was most common in the antithrombotic associated and 
post surgical group. 
ICH at Randomization 
374 scans at randomization were included in this analysis. Difference plots (figure 1) 
revealed that the ABC/2.4 method (B) had the smallest slope (y=0.10x-3.64; 95% CI 
of intercept +13.71, -20.99) with the 2/3SC method (D) having the smallest 95% 
limits of agreement (y=0.20x-3.12, +9.98, -16.22). The ABC/2 method (A) was 
inferior to these two methods (y=0.29x-4.23, +14.6, -23.07) whilst the ABC/3 method 
(C) underestimated ICH volume significantly (y= -0.10x-3.64, +13.71, -20.99). 
Agreement to the semi-automatically segmented (ROI) volume was also assessed in 
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the randomization group by looking at volumes calculated ≤ 5mls or ≤ 20% of that of 
their ROI volume (Supplementary Figure II), as used by Webb et al.15. In this 
analysis, the ABC/2.4 and 2/3SC methods performed significantly (p<0.0001) better 
than the ABC/2 or ABC/3 method in both categories. There was a trend but not 
statistical significance to supporting ABC/2.4 as the most accurate method for 
categorizing scans within 20% of ROI volume (p=0.0723).   
Post-operative ICH 
206 post-operative scans were included in this study (figure 2). The ABC/3 method 
(C) had the smallest slope (y=0.06x-0.65, +12.53, -13.84), followed by ABC/2.4 
method (B) (y=0.29x-0.82, +13.72, -15.48) and the 2/3SC method (D) (y=0.31x-0.14, 
+10.47, -10.75). The ABC/2 method (A) had the largest slope and 95% limits in this 
group (y=0.47x-0.97, +14.75, 16.69).  
Antithrombotic associated ICH 
Antithrombotic associated ICH is more frequently irregular in shape and therefore 
more prone to ICH volume estimation error.10, 19 79 patients at randomization were 
included taking one or more of an anticoagulant, antiplatelets or thrombolytics (Table 
1). Of these: 24/79 (30.38%) were taking only an anticoagulant, 42/79 (53.16%) were 
taking only an antiplatelet and 0 (0%) patients were taking only thrombolytic. 8 
(10.13%) patients were taking an anticoagulant and an antiplatelet and 4 (5.06%) 
patients were on anticoagulation with a thrombolytic. 0 (0%) were on an antiplatelet 
and thrombolytic. 1 (1.27%) patient was taking all 3 medications described above. 
The ABC/2.4 method (B) had the closest agreement (y=0.03x-1.33, +18.84, -21.50) 
(Figure 3). The 2/3SC method (D) followed (y=0.13x-1.30, +11.56, -14.15) with the 
smallest limits of agreement. The ABC/2 method (A) was inferior (y=0.22x-1.87, 
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+20.10, -23.85). The ABC/3 method (C) was found to considerably underestimate 
ICH volume in this group (y=-0.20x-0.75, +17.20, -18.71).  
Irregular shaped ICH 
703 scans were included in this study that were classified as irregular shape on the 
largest slice of haemorrhage using the Barras ordinal groups 3-5 (See Table 2). 
13.37% (94) were group 3, 24.75% (174) were group 4 and 61.88% (435) were group 
5. Agreement was greatest for the ABC/2.4 method (y=0.08x-1.2, +16.08, -18.48) and 
the 2/3SC method (y=0.17x-0.74, +12.69, -14.17) (Figure 4). ABC/3 underestimated 
ICH volume (y=-0.15x-0.88, +14.54, -16.31) whilst ABC/2 overestimated ICH 
volume (y=0.27x-1.49, +17.29, -20.27).  
Heterogeneous density ICH 
650 scans were classified as having heterogeneous density on largest slice of 
haemorrhage using the Barras ordinal groups 3 to 5. 23.85% (155) were group 3, 
17.54% (114) were group 4 and 58.62% (381) were group 5 (Table 2). Difference 
plots for ICH volume (Supplementary Figure III) showed a similar pattern for 
irregular density haematomas as irregular shape haematomas with ABC/2.4 (y=0.08x-
1.18, +16.62, -18.98) and 2/3SC (y=0.17x-0.76, +13.20, -14.71) having greater 
agreement than ABC/2 (y=0.27x-1.48, +17.87, -20.82) and ABC/3 (y=-0.15x-0.85, 
+15.04, -16.74).  
Discussion 
This study used the validated OsiriX ROI method as the reference standard against 
which to evaluate other methods of ICH volume estimation. We have validated the 
use of the ABC/2.4 method for a broad group of spontaneous supratentorial ICH. The 
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ABC/2.4 method showed the greatest agreement for: randomization ICH volume, 
antithrombotic associated-, irregularly shaped- and heterogeneous density 
haemorrhages. This finding challenges the use of the ABC/2 method, having poorer 
agreement to ABC/2.4. Indeed the ABC/2 method was also inferior to the 2/3SC 
method. However, the 2/3SC method relies on accurate measurement of the largest 
axial area of heamorrhage (cm2) and requires segmentation software for calculation. 
The ABC/3 method significantly underestimated haemorrhage in all but the 3-7-day 
post surgical group. It is interesting that the ABC/3 performed particularly poorly in 
this study with antithrombotic associated haemorrhages. This is contrary to Huttner et 
al. who demonstrated closer agreement between planimetry and ABC/3 than with 
ABC/2 for irregular warfarin-related haemorrhages.17 It must be stated that our 
sample size in this group of antithrombotic associated ICH was small (n=79) and our 
patient group were on a combination of anticoagulants, anti-platelets and 
thrombolytics. However this study did find the ABC/3 method had the closest 
agreement for measuring postoperative ICH volume. This finding has implications for 
volume reduction clinical trials in ICH, when post intervention ICH volume is an 
important outcome measure and sa1fety criterion. Its clinical implication is potentially 
useful in patients who require re-imaging following surgical evacuation. It is 
hypothesized by the authors that the increase in denominator seeks to account for 3-7 
day ICH being less elliptical in shape, with any residual haematoma likely to form in 
a non-elliptical shape. This is supported by analysis of matched scans from pre- and 
post-intervention showing a non statistically significant trend towards increasing 
Barras shape and a significant trend towards decreasing Barras density at 3-7 days 
(Supplementary Table I).        
 There are several limitations to the work presented above, firstly 
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there was a selection bias to scans in the STICH II image archive that were 
compatible with OsiriX image viewer, this meant that more scans were from patients 
who had been recruited from ‘Western centres”, patients who had their initial scan at a 
remote centre were less likely to have compatible scans. Scans were read by one 
reader (MH) after a period of training in an experienced ICH imaging laboratory, and 
as such there are no intra- or inter-rater reliability statistics for this patient selection. 
Comparison to randomization ABC/2 volumes published in STICH II is not possible 
due to different selection criteria. The Barras Shape and Density are limited by only 
assessing the largest slice of haemorrhage and a “ceiling effect” with a maximum 
score of five.  
Conclusion 
In conclusion this study has validated the ABC/2.4 method for accurately calculating 
ICH volume across a number of specified groups relevant to clinical practice. This 
finding challenges the routine use of the ABC/2 for all but the simplest ellipsoid 
haemorrhages. The ABC/3 method was found to be particularly accurate for 
calculating post surgical ICH volumes. 
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Figure Legends 
1. Difference plots comparing ICH volume at randomization measured by ROI 
with ABC/2 (A) ABC/2.4 (B), ABC/3 (C) and 2/3SC (D). Data includes the 
first eligible scan for each patient in the STICH II trial. Linear regression of 
volume difference on mean volume: (A) y=0.29x-4.23, (B) y=0.10x-3.64, (C) 
y=-0.13x-2.97, (D) y=0.20x-3.12. 95% confidence intervals constructed by 
linear regression of residuals: (A) y=0.29x+14.60, y=0.29x-23.07 (B) 
y=0.10x+13.71, y=0.10x-20.99, (C) y=-0.13x+12.54, y=-0.13x-18.47 (D) 
y=0.20x+9.98, y=0.20x-16.22 
2. Difference plots comparing ICH post-surgical volume 3-7 day measured by 
ROI with ABC/2 (A) ABC/2.4 (B), ABC/3 (C) and 2/3SC (D). Data includes 
the post-operative eligible scan for each patient in the STICH II trial. Linear 
regression of volume difference on mean volume: (A) y=0.47x-0.97, (B) 
y=0.29x-0.82, (C) y=0.06x-0.65, (D) y=0.31x-0.14. 95% confidence intervals 
constructed by linear regression of residuals: (A) y=0.47x+14.75, y=0.47x-
16.69 (B) y=0.29x+13.72, y=0.29x-15.48, (C) y=0.06x+12.53, y=0.06x-13.84 
(D) y=0.31x+10.47, y=0.31x-10.75 
3. Difference plots comparing ICH volume for patients with antithrombotic 
associated ICH measured by ROI with ABC/2 (A) ABC/2.4 (B), ABC/3 (C) 
and 2/3SC (D). Data includes the first eligible scan for each patient in the 
STICH II trial. Linear regression of volume difference on mean volume: (A) 
y=0.22x-1.87, (B) y=0.03x-1.33, (C) y=-0.20x-0.75, (D) y=0.13x-1.3. 95% 
confidence intervals constructed by linear regression of residuals: (A) 
y=0.22x+20.10, y=0.22x-23.85 (B) y=0.03x+18.84, y=0.03x-21.50, (C) y=-
0.20x+17.20, y=-0.20x-18.71 (D) y=0.13x+11.56, y=0.13x-14.15 
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4. Difference plots comparing ICH volume for scans with Barras Shape 3-5 by 
ROI with ABC/2 (A) ABC/2.4 (B), ABC/3 (C) and 2/3SC (D). Linear 
regression of volume difference on mean volume: (A) y=0.27x-1.50, (B) 
y=0.08x-1.20, (C) y=-0.15x-0.88, (D) y=0.17x-0.75. 95% confidence intervals 
constructed by linear regression of residuals: (A) y=0.27x+17.87, y=0.27x-
20.82 (B) y=0.08x+16.08, y=0.08x-18.48, (C) y=-0.15x-16.31, y=-0.15x+14.54 
(D) y=0.17x+12.69, y=0.17x-14.17 
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Table 1 Characteristics of included patients. Data are mean (Standard Deviation-SD), 
median (Interquartile Range-IQR, Range) or frequency (%).  
 
All 
patients 
(n=390) 
Patients with 
Randomisation 
scan 
(n=374) 
Patients 
post 
surgery 
with ICH 
on 3-7-day 
(n=206) 
Patients with 
antithrombo
tic 
associated 
ICH 
(n=79) 
Patients 
with 
Irregular 
shape 
ICH 
(n=386) 
Patients 
with 
Irregular 
density 
ICH 
(n=370) 
Age Mean 
(SD) 
65.2 
(12.9) 
65.6 (12.6) 65.3 
(12.5) 
69.2 (10.2) 65.2 
(12.9) 
65.2 
(12.8) 
Male (%) 209 (53.6) 198 (52.9) 104 (50.5) 43 (54.4) 206 (53.4) 197 (53.2) 
Glasgow Coma 
Score 
3-8 (%) 
9-12 (%) 
13-15 (%) 
12 (3.1) 
124 (31.8) 
254 (65.1) 
11 (2.9) 
120 (32.1) 
243 (65.0) 
10 (4.9) 
68 (33.0) 
128 (62.1) 
2 (2.5) 
23 (29.1) 
54 (68.4) 
12 (3.1) 
123 (31.9) 
251 (65.0) 
12 (3.2)  
117 (31.6) 
241 (65.1) 
Hypertension 
(%) 255 (65.4) 248 (66.3) 137 (66.5) 58 (73.4) 252 (65.3) 243 (65.7) 
On hypertension 
medication (%) 189 (48.5) 183 (48.9) 99 (48.1) 52 (65.8) 188 (48.7) 180 (48.6) 
Previous 
myocardial 
infarction (%) 26 (6.7) 26 (7.0) 16 (7.8) 18 (22.8) 25 (6.5) 25 (6.8) 
Previous stroke 
(%) 54 (13.9) 50 (13.4) 30 (14.6) 17 (21.5) 54 (14.0) 53 (14.3) 
On 
Anticoagulation 
(%) 37 (9.5) 37 (9.9) 17 (8.3) 37 (46.8) 37 (9.6) 36 (9.7) 
On antiplatelet 
(%) 53 (13.6) 51 (13.6) 29 (14.1) 51 (64.6) 53 (13.7) 52 (14.1) 
On thrombolytic 
(%) 5 (1.3) 5 (1.3) 3 (1.5) 5 (6.3) 5 (1.3) 5 (1.4) 
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Table 2 Characteristics of included scans. Data are mean (Standard Deviation, SD), 
median (Interquartile Range IQR, Range) or frequency (%).  
  
All 
Scans 
(n=739) 
Randomisation  
scans (n=374) 
Post op 
Scans  
(n=206) 
Antithromb
otic 
associated 
Scans 
(n=79) 
Irregular 
shape 
Scans  
(n=703) 
Irregular 
density 
Scans 
 (n=650) 
Side 
 
Left (%) 
Right (%) 
Bilateral (%) 
394 (53.3) 
342 (46.3) 
3 (0.4) 
199 (53.2) 
174 (46.5) 
1 (0.3) 
106 (51.5) 
98 (47.6) 
2 (1.0) 
31 (39.2) 
48 (60.8) 
0 (0) 
371 (52.8) 
329 (46.8) 
3 (0.4) 
339 (52.2) 
309 (47.5) 
2 (0.3) 
Deep 
(%) 
190 (25.7) 
90  
(24.1) 
57  
(27.7) 
24 
 (30.4) 
183  
(26.0) 
166  
(25.5) 
Primary 
Lobe 
Affected 
Frontal (%) 
Temporal 
(%) 
Parietal (%) 
Occipital (%) 
207 (28.0) 
231 (31.3) 
237 (32.1) 
64 (8.7) 
103 (27.5) 
114 (30.5) 
123 (32.9) 
34 (9.1) 
59 (28.6) 
61 (29.6) 
70 (34.0) 
16 (7.8) 
27 (34.2) 
19 (24.1) 
19 (24.1) 
14 (17.7) 
199 (28.3) 
218 (31.0) 
225 (32.0) 
61 (8.7) 
183 (28.2) 
212 (32.6) 
201 (30.9) 
54 (8.3) 
Region of 
Interest 
(ROI) 
Mean 
Volume 
(SD) 
35.4 
(26.8) 
45.6 
 (24.2) 
12.9 
(18.5) 
51.2 
(25.2) 
36.2 
(27.0) 
37.3 
(27.2) 
Barras Shape 
Mean (SD) 
4.4 (0.9) 4.4 (0.9) 4.42 (0.9) 4.37 (0.9) 4.49 (0.7) 4.5 (0.8) 
Barras 
Density 
Mean (SD) 
4.05 (1.1) 4.07 (1.1) 4.16 (1.2) 4.32 (1.0) 4.14 (1.1) 4.35 (0.8) 
Intraventricu
lar 
Haemorrhag
e 
(%) 
104  
(14.1) 
46 
(12.3) 
36  
(17.5) 
14 
(17.7) 
102 
(14.5) 
94 
(14.5) 
 




 SUPPLEMENTAL MATERIAL 
Supplementary Table I: Comparisons of Barras ordinal shape and density scales before and after surgery utilising matched scans (n=195) 
Barras Shape 
Score I II III IV V Totals 
Matched 
randomisation 
scans (n=195) 
1 7 17 51 119 195 
Matched post 
operative scans 
(n=195) 
3 8 22 35 127 195 
Fisher’s exact test for significance for change in Barras Shape Score p= 0.298 (p>0.05) 
There is a non-statistically significant change in Barras Shape Scores between matched randomisation and postoperative 
scans. 
Barras Density 
Score I II III IV V Totals 
Matched 
randomisation 
scans (n=195) 
0 14 37 39 105 195 
Matched post 
operative scans 
(n=195) 
6 17 37 16 119 195 
Fisher’s exact test for significance for change in Barras Density Score p= 0.001 (p<0.05) 
There is a statistically significant change in Barras Density Scores between matched randomisation and postoperative scans. 
There is a significant trend to decreasing Barras Density scores post operatively. 
 
 739 scans for final 
analysis 
1202 potential 
scans 
1165 available 
scans 
754 scans able to 
be analysed 
37 scans including: withdrawals, lost, not 
done, not complete, not available or 
deceased before second scan 
411 scans not compatible with open 
source DICOM viewer (OsiriX Lite v.6.5 
32-bit, PIXMEO, Geneva; Switzerland)  
15 studies excluded due to a zero volume 
of ICH on scan 
Supplementary Figure I: Patient selection flow diagram 
 
Supplementary Figure II – Number of randomisation scans ≤ 5mls (A) or 
(B) ≤ 20% of ROI volume. Statistical significance determined using 
Fisher’s Exact Test. (**** = P<0.0001).  
  
Supplementary Figure III: Bland-Altman Plots comparing ICH volume for scans with Barras Density 3-5 measured by region of interest (ROI) 
volume with ABC/2 (A) ABC/2.4 (B), ABC/3 (C) and 2/3SC (D) measured in centrimetres cubed (cm3). Linear regression of volume 
difference on mean volume: (A) y=0.27x-1.5, (B) y=0.08x-1.2, (C) y=-0.15x-0.88, (D) y=0.17x-0.74. 95% confidence intervals constructed by 
linear regression of residuals: (A) y=0.27x+17.29, y=0.27x-20.27 (B) y=0.08x+16.08, y=0.08x-18.48, (C) y=-0.15x+14.54, y=-0.15x-16.31 (D) 
y=0.17x+12.69, y=0.17x-14.17 
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